Bharat Biotech's TB vaccine MTBVAC begins clinical trials in India
Developed by Biofabri in collaboration with the Hyderabad-based Bharat Biotech, MTBVAC is derived from a human strain of the Mycobacterium tuberculosis bacteria
Developed by Biofabri in collaboration with the Hyderabad-based Bharat Biotech, MTBVAC is derived from a human strain of the Mycobacterium tuberculosis bacteria